News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
153,490 Results
Type
Article (6816)
Company Profile (6)
Press Release (146667)
Multimedia
Podcasts (8)
Webinars (3)
Section
Business (47173)
Career Advice (263)
Deals (7240)
Drug Delivery (31)
Drug Development (16001)
Employer Resources (13)
FDA (4920)
Job Trends (2889)
News (69958)
Policy (5677)
Tag
Academia (578)
Accelerated approval (15)
ADA (6)
Adcomms (2)
Allergies (57)
Alliances (8645)
ALS (42)
Alzheimer's disease (421)
Antibody-drug conjugate (ADC) (127)
Approvals (5136)
Artificial intelligence (110)
ASCO (63)
Autoimmune disease (64)
Automation (10)
Bankruptcy (59)
Best Places to Work (2525)
BIO (15)
BIOSECURE Act (2)
Biosimilars (76)
Biotechnology (7)
Bladder cancer (86)
Brain cancer (26)
Breast cancer (178)
Cancer (1536)
Cardiovascular disease (117)
Career advice (223)
Career pathing (3)
CAR-T (59)
CDC (9)
Cell therapy (209)
Cervical cancer (15)
Clinical research (14215)
Collaboration (372)
Company closure (1)
Compensation (99)
Complete response letters (16)
COVID-19 (598)
CRISPR (23)
C-suite (189)
Cystic fibrosis (25)
Data (2241)
Denatured (1)
Depression (36)
Dermatology (23)
Diabetes (145)
Diagnostics (1519)
Digital health (18)
Diversity (2)
Diversity, equity & inclusion (3)
Drug discovery (72)
Drug pricing (44)
Drug shortages (4)
Duchenne muscular dystrophy (45)
Earnings (26341)
Editorial (12)
Employer branding (3)
Employer resources (15)
Events (24847)
Executive appointments (151)
FDA (6132)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (8)
Frontotemporal dementia (4)
Funding (341)
Gene editing (57)
Generative AI (4)
Gene therapy (223)
GLP-1 (238)
Government (783)
Grass and pollen (2)
Guidances (165)
Healthcare (5047)
Hematology (27)
HIV (11)
Huntington's disease (13)
IgA nephropathy (32)
Immunology and inflammation (51)
Immuno-oncology (13)
Indications (57)
Infectious disease (660)
Inflammatory bowel disease (46)
Inflation Reduction Act (1)
Influenza (31)
Intellectual property (60)
Interviews (43)
IPO (3732)
IRA (10)
Job creations (420)
Job search strategy (190)
JPM (14)
Kidney cancer (1)
Labor market (33)
Layoffs (109)
Leadership (7)
Legal (1059)
Liver cancer (35)
Longevity (9)
Lung cancer (207)
Lymphoma (87)
Machine learning (14)
Management (6)
Manufacturing (234)
Marketing (2)
MASH (23)
Medical device (6293)
Medtech (6374)
Mergers & acquisitions (3781)
Metabolic disorders (323)
mRNA (54)
Multiple sclerosis (54)
Neurodegenerative disease (82)
Neuropsychiatric disorders (16)
Neuroscience (745)
Neurotech (1)
NextGen: Class of 2026 (1383)
Non-profit (714)
Now hiring (7)
Obesity (139)
Opinion (54)
Ovarian cancer (73)
Pain (131)
Pancreatic cancer (115)
Parkinson's disease (91)
Partnered (8)
Patents (123)
Patient recruitment (204)
Peanut (30)
People (7926)
Pharmaceutical (9)
Pharmacy benefit managers (4)
Phase 1 (4462)
Phase 2 (6511)
Phase 3 (4721)
Pipeline (2700)
Policy (58)
Postmarket research (380)
Preclinical (1939)
Press Release (10)
Prostate cancer (80)
Psychedelics (7)
Radiopharmaceuticals (52)
Rare diseases (233)
Real estate (748)
Recruiting (7)
Regulatory (5243)
Reports (11)
Research institute (495)
Resumes & cover letters (39)
Rett syndrome (10)
RNA editing (9)
RSV (11)
Schizophrenia (19)
Series A (52)
Series B (32)
Service/supplier (1)
Sickle cell disease (22)
Special edition (5)
Spinal muscular atrophy (26)
Sponsored (11)
Startups (602)
Stomach cancer (1)
Supply chain (35)
Tariffs (11)
The Weekly (7)
Vaccines (232)
Venture capital (25)
Weight loss (99)
Women's health (39)
Worklife (4)
Date
Today (33)
Last 7 days (95)
Last 30 days (373)
Last 365 days (7096)
2026 (3864)
2025 (7133)
2024 (8057)
2023 (9854)
2022 (14029)
2021 (14103)
2020 (13173)
2019 (9966)
2018 (7394)
2017 (7144)
2016 (6573)
2015 (8048)
2014 (5906)
2013 (4863)
2012 (5226)
2011 (5272)
2010 (4590)
Location
Africa (98)
Alabama (37)
Alaska (3)
Arizona (71)
Arkansas (4)
Asia (8180)
Australia (1474)
California (2810)
Canada (798)
China (269)
Colorado (196)
Connecticut (130)
Delaware (101)
Europe (19882)
Florida (609)
Georgia (209)
Idaho (15)
Illinois (279)
India (24)
Indiana (213)
Iowa (3)
Japan (162)
Kansas (18)
Kentucky (6)
Louisiana (11)
Maine (27)
Maryland (361)
Massachusetts (1928)
Michigan (113)
Minnesota (338)
Mississippi (4)
Missouri (72)
Montana (12)
Nebraska (7)
Nevada (35)
New Hampshire (20)
New Jersey (907)
New Mexico (7)
New York (795)
North Carolina (511)
North Dakota (2)
Northern California (1395)
Ohio (130)
Oklahoma (5)
Oregon (11)
Pennsylvania (791)
Puerto Rico (5)
Rhode Island (14)
South America (140)
South Carolina (15)
Southern California (1204)
Tennessee (103)
Texas (498)
United States (11356)
Utah (140)
Virginia (76)
Washington D.C. (6)
Washington State (167)
West Virginia (3)
Wisconsin (14)
153,490 Results for "via surgical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Press Release: Sanofi’s subcutaneous Sarclisa Escena approved in the US as first anticancer treatment administered via on-body injector
July 13, 2026
·
11 min read
Press Releases
RenovoRx Highlights Peer-Reviewed Publication Supporting Intra-Arterial Gemcitabine Delivery Via TAMP™ in Locally Advanced Pancreatic Cancer
June 11, 2026
·
10 min read
Press Releases
TempraMed Expands Strategic Partnership with McKesson Medical-Surgical to Accelerate North American Growth and Launch Full Portfolio Across B2B Channels
Integration into McKesson’s Medical-Surgical Solutions marketplace serving a nationwide customer base
June 30, 2026
·
6 min read
Press Releases
Nabsys Announces Advancements in Detection of Repeat Contraction and Expansion Disorders Via Electronic Genome Mapping in Collaboration with Leading European Institutions
June 15, 2026
·
5 min read
Press Releases
Peer-reviewed publication shows that Lateral pharma’s SCP drugs for neuropathic pain act via the novel target LanCL1
June 11, 2026
·
3 min read
Press Releases
Press Release: Sanofi’s Sarclisa subcutaneous approved in the EU as the first anticancer treatment administered via an on-body injector
June 8, 2026
·
12 min read
Press Releases
GENFIT: NASHnext®, Powered by GENFIT’s Non-invasive Diagnostic Technology NIS4®, Launched via Labcorp’s OnDemand Offering for Identification of At-Risk MASH
June 9, 2026
·
9 min read
Press Releases
Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds
June 22, 2026
·
14 min read
Press Releases
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
April 24, 2026
·
11 min read
Press Releases
LEM Surgical Announces second FDA 510(k) Clearance for Next-Generation Humanoid Robotic Surgical System
June 23, 2026
·
2 min read
1 of 15,349
Next
